Express Pharma October 2024
India's Foremost Pharma & Biotech Magazine ~ Goa: Catalysing Innovation And Growth
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Piramal Pharma Solutions announces $80M expansion at Lexington Facility
Investment to boost capacity for sterile injectable drug manufacturing, create 40 new jobs in Kentucky
GlobalData poll reveals microbiome’s essential role in health
The poll reveals that 90 per cent of the respondents consider the microbiome to be very important for health maintenance
Alembic gains EIR for its Oral Solid Formulation Facility(F-1) at Panelav
The inspection took place from July 17, 2024, to July 26, 2024
Revenues to increase by 9-11 % for Indian pharma companies in FY2025: ICRA
Revenues estimated to increase by 9-11 per cent from the US market, and 7-9 per cent each from the European and the domestic…
Venus Remedies gets marketing authorisations for oncology drugs from Morocco, Philippines
Marketing approvals for bortezomib from Philippines and carboplatin from Morocco aims to enhance its presence in ASEAN, African…
Critical to make a clear distinction between NSQ and Spurious Drugs: IPA
The association claims that the media has interchanged the terms “Not of Standard Quality” and “Spurious” in reports about a CDSCO…
Alkem Laboratories denies claims of substandard quality for Pan-D and Clavam 625
Company asserts that reported samples are spurious and not manufactured by Alkem
Lupin partners with Celnova Pharma to distribute NaMuscla in Argentina and Colombia
NaMuscla (mexiletine) to be commercialised for the treatment of non-dystrophic myotonic disorders in adults
Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets
Approval covers Paliperidone tablets for the treatment of schizophrenia and schizoaffective disorder